This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1994 May;14(3):253-60.

Immune system dysregulation in uremia

B Descamps-Latscha¹, A Herbelin, A T Nguyen, J Zingraff, P Jungers, L Chatenoud

Affiliations

PMID: 8036360

Review

Immune system dysregulation in uremia

B Descamps-Latscha et al. Semin Nephrol. 1994 May.

. 1994 May;14(3):253-60.

Authors

B Descamps-Latscha¹, A Herbelin, A T Nguyen, J Zingraff, P Jungers, L Chatenoud

Affiliation

¹ Nephrology Department, INSERM U25, INSERM U90, Hôpital Necker, Paris, France.

PMID: 8036360

No abstract available

PubMed Disclaimer

Similar articles

Immune dysfunction in uremia.
Cohen G, Haag-Weber M, Hörl WH. Cohen G, et al. Kidney Int Suppl. 1997 Nov;62:S79-82. Kidney Int Suppl. 1997. PMID: 9350688 Review.
T cells and B cells in chronic renal failure.
Descamps-Latscha B, Chatenoud L. Descamps-Latscha B, et al. Semin Nephrol. 1996 May;16(3):183-91. Semin Nephrol. 1996. PMID: 8734461 Review.
Plasmapheresis holds distinct advantages for 21st century uremia therapy.
Nose Y, Smith JW, Malchesky PS. Nose Y, et al. Kidney Int Suppl. 1985 Dec;17:S131-2. Kidney Int Suppl. 1985. PMID: 3867783 No abstract available.
Increase of peripheral natural killer T cells in hemodialysis patients.
Nishimoto A, Matsumoto Y. Nishimoto A, et al. Clin Nephrol. 2001 Feb;55(2):121-6. Clin Nephrol. 2001. PMID: 11269675
Molecular aspects of T- and B-cell function in uremia.
Girndt M, Sester M, Sester U, Kaul H, Köhler H. Girndt M, et al. Kidney Int Suppl. 2001 Feb;78:S206-11. doi: 10.1046/j.1523-1755.2001.59780206.x. Kidney Int Suppl. 2001. PMID: 11169012 Review.

See all similar articles

Cited by

Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis.
Kim HW, Woo YS, Yang HN, Choi HM, Jo SK, Cho WY, Kim HK. Kim HW, et al. Clin Exp Nephrol. 2011 Apr;15(2):258-63. doi: 10.1007/s10157-010-0379-8. Epub 2010 Dec 9. Clin Exp Nephrol. 2011. PMID: 21152946
Impact of vitamin D supplementation on arterial vasomotion, stiffness and endothelial biomarkers in chronic kidney disease patients.
Chitalia N, Ismail T, Tooth L, Boa F, Hampson G, Goldsmith D, Kaski JC, Banerjee D. Chitalia N, et al. PLoS One. 2014 Mar 19;9(3):e91363. doi: 10.1371/journal.pone.0091363. eCollection 2014. PLoS One. 2014. PMID: 24646518 Free PMC article. Clinical Trial.
Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population.
Ng YY, Wu SC, Lin HD, Hu FH, Hou CC, Chou YY, Chiu SM, Sun YH, Cho SS, Yang WC. Ng YY, et al. Perit Dial Int. 2012 Jan-Feb;32(1):86-93. doi: 10.3747/pdi.2010.00202. Epub 2011 Apr 30. Perit Dial Int. 2012. PMID: 21532003 Free PMC article.
The clinical diagnosis of heparin-induced thrombocytopenia in patients receiving continuous renal replacement therapy.
Holmes CE, Huang JC, Cartelli C, Howard A, Rimmer J, Cushman M. Holmes CE, et al. J Thromb Thrombolysis. 2009 May;27(4):406-12. doi: 10.1007/s11239-008-0228-8. Epub 2008 May 17. J Thromb Thrombolysis. 2009. PMID: 18488144
A benefit-risk assessment of basiliximab in renal transplantation.
Boggi U, Danesi R, Vistoli F, Del Chiaro M, Signori S, Marchetti P, Del Tacca M, Mosca F. Boggi U, et al. Drug Saf. 2004;27(2):91-106. doi: 10.2165/00002018-200427020-00002. Drug Saf. 2004. PMID: 14717621

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information